Compare Standard Lithium Ltd (SLI) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Standard Lithium Ltd vs TransMedics Group Inc — how do they compare? Standard Lithium Ltd trades at $2.27 (market cap $523.89M), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TransMedics Group Inc is far larger — about 4.8× Standard Lithium Ltd's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| SLI | TMDX | |
|---|---|---|
Market Cap | $523.89M | $2.54B |
Sector | Basic Materials | Technology |
52-Week High | $5.65 | $150.42 |
52-Week Low | $2.15 | $61.99 |
Enterprise Value | $383.09M | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
